[Daejeon, Republic of Korea – April 7, 2020] Bioneer (CEO Han-oh Park) specializing in molecular diagnostics announced that it has signed an agreement with Qatar Petroleum, a state-owned company, to supply $4 million worth molecular diagnostic instruments and coronavirus detection kits in Qatar.
Under the agreement, Bioneer will supply Qatar Petroleum with COVID-19 molecular diagnostic kits, nucleic acid extraction reagents and 18 molecular diagnostic instruments such as ExiPrep™ 96 Lite and Exicycler™. Supplied instruments and kits for COVID-19 molecular diagnosis will be applied in medical institutions including the Medical Services Department of Qatar Petroleum.
Bioneer provides a total solution for molecular diagnosis with its gene extraction instrument, real-time PCR instrument, extraction reagents and assays for amplifying and analyzing genes required for COVID-19 detection and diagnostics. All Bioneers instruments, reagents and kits are developed by the proprietary technologies in-house.
Exhibitor Data Sheet